» Articles » PMID: 17410603

Effects of Polyethylene Glycol and Magnesium Sulfate Administration on Clinically Relevant Neurological Outcomes After Spinal Cord Injury in the Rat

Overview
Journal J Neurosci Res
Specialty Neurology
Date 2007 Apr 6
PMID 17410603
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to determine the long-term effects of polyethylene glycol (PEG) and magnesium sulfate (MgSO(4)) on clinically relevant motor, sensory, and autonomic outcomes after spinal cord injury (SCI). Rats were injured by clip compression (50 g; T4) and treated 15 min and 6 hr postinjury intravenously (tail vein) with PEG (1 g/kg, 30% w/w in saline; n = 11), MgSO(4) (300 mg/kg; n = 5), PEG + MgSO(4) (n = 6), or saline (n = 10). Behavioral testing lasted for 6 weeks, followed by histological analysis of the spinal cord. Both PEG and MgSO(4) resulted in enhanced locomotor recovery and lower susceptibility to neuropathic pain (mechanical allodynia) compared with saline. At 6 weeks, BBB scores were 7.3 +/- 0.2, 7.7 +/- 0.4, and 6.4 +/- 0.6 in PEG-treated, MgSO(4)-treated, and saline-treated control groups, respectively. Likewise, at 6 weeks PEG-, MgSO(4)-, and saline-treated control animals showed 3.5 +/- 0.4, 2.8 +/- 0.9, and 5.0 +/- 0.5 avoidance responses to at-level touch, respectively. PEG + MgSO(4) improved locomotor recovery and reduced pain but did not provide additional benefit compared with either treatment alone. Neither treatment, nor their combination, attenuated mean arterial pressure (MAP) increases during autonomic dysreflexia. However, saline-treated controls had significantly lower resting MAP than PEG-treated rats and tended to have lower resting MAP than MgSO(4)-treated rats 6 weeks postinjury. MgSO(4) treatment and PEG + MgSO(4) treatment resulted in significant increases in dorsal myelin sparing, and the latter resulted in significant reductions in lesion volume, compared with saline-treated controls. Furthermore, mean lesion volumes correlated negatively with the corresponding mean BBB scores and positively with the corresponding mean pain scores. In conclusion, both PEG and MgSO(4) enhanced long-term clinical outcomes after SCI.

Citing Articles

Advancements in neuroregenerative and neuroprotective therapies for traumatic spinal cord injury.

Fischer G, Battig L, Stienen M, Curt A, Fehlings M, Hejrati N Front Neurosci. 2024; 18:1372920.

PMID: 38812974 PMC: 11133582. DOI: 10.3389/fnins.2024.1372920.


A Mini Review on the Various Facets Effecting Brain Delivery of Magnesium and Its Role in Neurological Disorders.

Mathew A, Panonnummal R Biol Trace Elem Res. 2022; 201(9):4238-4253.

PMID: 36534337 DOI: 10.1007/s12011-022-03517-8.


Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem.

Griffin J, Bradke F EMBO Mol Med. 2020; 12(3):e11505.

PMID: 32090481 PMC: 7059014. DOI: 10.15252/emmm.201911505.


The Role of Magnesium in the Secondary Phase After Traumatic Spinal Cord Injury. A Prospective Clinical Observer Study.

Sperl A, Heller R, Biglari B, Haubruck P, Seelig J, Schomburg L Antioxidants (Basel). 2019; 8(11).

PMID: 31653023 PMC: 6912766. DOI: 10.3390/antiox8110509.


Functional and Structural Improvement with a Catalytic Carbon Nano-Antioxidant in Experimental Traumatic Brain Injury Complicated by Hypotension and Resuscitation.

Mendoza K, Derry P, Cherian L, Garcia R, Nilewski L, Goodman J J Neurotrauma. 2019; 36(13):2139-2146.

PMID: 30704349 PMC: 6602099. DOI: 10.1089/neu.2018.6027.